XML 28 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' INVESTMENT (USD $)
12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Jan. 28, 2012
Common Stock [Member]
Jan. 29, 2011
Common Stock [Member]
Jan. 30, 2010
Common Stock [Member]
Jan. 31, 2009
Common Stock [Member]
Jan. 28, 2012
Paid-in Capital [Member]
Jan. 29, 2011
Paid-in Capital [Member]
Jan. 30, 2010
Paid-in Capital [Member]
Jan. 31, 2009
Paid-in Capital [Member]
Jan. 28, 2012
Retained Earnings [Member]
Jan. 29, 2011
Retained Earnings [Member]
Jan. 30, 2010
Retained Earnings [Member]
Jan. 31, 2009
Retained Earnings [Member]
Jan. 28, 2012
Treasury Stock [Member]
Jan. 29, 2011
Treasury Stock [Member]
Jan. 30, 2010
Treasury Stock [Member]
Jan. 31, 2009
Treasury Stock [Member]
Consolidated Statements of Stockholders' Investment [Roll Forward]                                
Balance-beginning of period       $ 363,000       $ 92,153,000       $ 211,003,000       $ (166,944,000)
Balance-beginning of period (in shares)       36,304,735                       7,761,813
Net income                 59,060,000 46,400,000 32,549,000          
Issuance of shares from the employee stock purchase plan and the exercise of stock options, including tax benefit 4,000 7,000 1,000   6,995,000 12,756,000 1,430,000                  
Issuance of shares from the employee stock purchase plan and the exercise of stock options, including tax benefit (in shares) 367,482 694,143 131,768                          
Tax shortfall on release of restricted stock and option exercises         51,000 67,000 6,000                  
Adjustment to income tax benefit from exercises of employee stock options         814,000 (1,024,000) 373,000                  
Purchase of shares under the stock repurchase program                         68,613,000 37,859,000 0  
Purchase of shares under the stock repurchase program (in shares)                         1,897,002 1,461,225 0  
Stock-based compensation         5,453,000 4,796,000 4,157,000                  
Balance-end of period $ 375,000 $ 371,000 $ 364,000 $ 363,000 $ 127,779,000 $ 114,568,000 $ 98,107,000 $ 92,153,000 $ 349,012,000 $ 289,952,000 $ 243,552,000 $ 211,003,000 $ (273,416,000) $ (204,803,000) $ (166,944,000) $ (166,944,000)
Balance-end of period (in shares) 37,498,128 37,130,646 36,436,503 36,304,735                 11,120,040 9,223,038 7,761,813 7,761,813